Soy Protein Isolate - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the soy protein isolate market size is expected to increase from USD 3.32 billion in 2025 to USD 3.45 billion in 2026 and reach USD 4.37 billion by 2031, growing at a CAGR of 4.84% over 2026-2031.

This report is Segmented by Category (Conventional and Organic), Application (Food and Beverages, Nutritional and Health Supplements, and Animal Feed), and Geography (North America, Europe, Asia-Pacific, South America, and the Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Soy Protein Isolate Market Trends and Insights

Rising Demand for Plant-Based Proteins in Mainstream Food and Beverages

Flexitarian diets are pushing plant proteins into the mainstream, with soy protein isolate making inroads into areas once dominated by dairy. By 2025, plant-based foods accounted for 13% of total protein sales in North America. This shift came as mainstream brands reformulated their products, incorporating soy isolates to cut costs and reduce carbon footprints, as highlighted by the Good Food Institute in 2024. In January 2026, Califia Farms introduced its Simple and Organic Soymilk, boasting just three ingredients: organic soybeans, water, and sea salt. With 8 grams of protein per serving, it's positioned to rival dairy milk in protein content while offering a more economical choice than almond and oat alternatives. This evolution is prompting beverage formulators to adjust their procurement strategies, recognizing that soy isolates provide a complete amino acid profile and boast a carbon footprint 7 to 70 times lighter than their animal protein counterparts, based on life-cycle assessments from IFF. Regulatory shifts are bolstering this momentum; while the FDA has broadened its GRAS notices for plant proteins to encompass pea, chickpea, and fava bean isolates, soy's decades of safety data and well-established supply chains grant it a distinct first-mover edge.

Accelerating Uptake in Meat-Alternative Formulations

After first-generation pea-protein burgers fell short on texture and binding, meat analog manufacturers have turned to soy protein isolate as their primary structural protein. In 2026, Rival Foods, in collaboration with THIS, introduced a plant-based steak to the UK market. Utilizing Shear Cell technology, they crafted fibers boasting 30 grams of protein per 100 grams, surpassing beef's protein density. Notably, this was achieved without artificial binders, and the product is now stocked in major retailers like Tesco, Waitrose, Sainsbury's, Morrisons, and Ocado. This move signifies a strategic shift: although the product description omits a mention of soy isolate, its protein density and clean-label stance resonate with high-purity isolate formulations. Such formulations empower manufacturers to champion "no artificial additives" claims while still achieving a meat-like texture. In 2025, Tyson Foods made a quiet yet significant move, investing in five plant-protein startups. Among these was a precision agriculture firm focused on enhancing pea and soy protein yields for food-grade uses. This investment underscores a notable trend: even processors traditionally centered on beef are now diversifying, eyeing the legume protein supply chains. Tyson's foray into upstream agronomy hints at a strategic foresight: an anticipation of tightening supplies or potential quality fluctuations in soy isolates as demand continues to rise. A key player in this evolution is extrusion technology. DSM-Firmenich's Vertis texturized vegetable proteins, leveraging the ModulaSENSE flavor-masking platform, have pushed the envelope. They've enabled soy isolate inclusion rates exceeding 20% in whole-muscle analogs, all without the dreaded off-notes.

Soy-Allergen Labeling and Consumer Perception Challenges

Despite soy's low clinical prevalence, some formulators view allergen labeling requirements as a marketing liability. The FDA's FALCPA mandates that soy, recognized as a major allergen, be plainly listed immediately after or within the ingredient list. Similarly, the EU's Food Information to Consumers Regulation emphasizes the need for typographical prominence. Manufacturers, adhering to the EU's 2026 allergen management requirements, must adopt comprehensive allergen management programs. These include physical line segregation, validated cleaning protocols, employee training, and thorough documentation. Failure to manage these controls can lead to recalls, fines, and significant reputational harm. Notably, while allergen concerns topped food-safety worries at 42% in a 2025 survey by the International Food Information Council, soy was mentioned only 4 times. This underscores a minimal consumer perception of soy as an allergen, especially when juxtaposed with concerns over peanuts, tree nuts, and shellfish. Strategically, while allergen labeling poses a compliance cost, it doesn't constrain demand. However, it does create a perception gap: some brands, aiming to sidestep allergen declarations, are shifting from soy isolates to pea or rice proteins. Yet, this comes with a caveat: achieving the same functionality with pea proteins demands higher inclusion rates. Consequently, the market is splitting: cost-sensitive formulators are accommodating allergen labeling, while premium brands, at a higher ingredient cost, are chasing an allergen-free image.

Other drivers and restraints analyzed in the detailed report include:

1. Functional Advantages in Sports and Active Nutrition
2. Expansion of Soy-Based Ingredients in Emerging Asian Markets
3. Soybean Price and Supply-Chain Volatility

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

In 2025, conventional soy protein isolate held 77.12% market share due to cost advantages and established supply chains. Organic soy protein isolate is projected to grow at 8.03% annually from 2026 to 2031, driven by clean-label mandates and retailer sustainability goals. Organic certification, requiring compliance with USDA or EU standards, prohibits synthetic pesticides, GMOs, and irradiation, reducing yields by 20-30% and increasing raw soybean costs by 30-50%. At the isolate level, smaller processing runs, dedicated equipment, and certification audits raise organic isolate prices 40-60% above conventional ones. Despite this, organic isolates are gaining traction in premium segments like sports nutrition, infant formula, and plant-based meats. Califia Farms' Simple and Organic Soymilk, launched in January 2026 at USD 5.99-6.99, highlights the premium potential of organic products in retail.

Conventional isolates dominate animal feed, commodity bakery, and processed meat applications, where the cost per gram of protein is critical. Bunge's BungePurePro Soy 70N family, with 69% protein, targets cost-sensitive aquaculture feed formulators prioritizing digestibility and anti-nutritional factor removal. Prairie AquaTech's ME-PRO, a fermented soybean protein powder with 73.4% crude protein, is available in GMO and non-GMO variants, showing segmentation within conventional isolates. The EU's Farm to Fork strategy, aiming for 25% organic farming by 2030, is expected to boost organic soybean supply and reduce premiums. Organic isolates are projected to capture 10-15% of market volume by 2031 as supply chains scale, while conventional isolates will continue dominating bulk applications prioritizing cost and functionality.

Geography Analysis

In 2025, North America held 33.40% of the soy protein isolate market, supported by the U.S.'s integrated crush-to-isolate infrastructure and Canada's non-GMO soybean production. However, margin compression persists as Asian manufacturers expand capacity and lower prices. Archer Daniels Midland invested USD 300 million in its Decatur, Illinois, facility to consolidate crush and protein extraction, but closed its Bushnell, Illinois, plant as part of a USD 500 to USD 700 million cost-cutting program targeting USD 200 to USD 300 million in annual savings. Bunge's USD 550 million Morristown facility, opened in autumn 2025, focuses on premium soy protein concentrate production. Mexico is emerging as a re-export hub, importing soy isolates from the U.S. and Canada for reformulation into foods for Latin American markets. The regulatory environment remains stable, with FDA GRAS status for soy proteins and IFF's March 2026 heart-health claim approval in Australia and New Zealand expected to influence Health Canada, opening opportunities for functional foods.

Asia-Pacific is projected to grow at 7.58% annually from 2026 to 2031, driven by capacity expansions in China and India, rising flexitarian consumption, and cost advantages in bulk isolate production. Yuwang Group processes 600,000 metric tons of soybeans, dedicating 130,000 metric tons to soy protein isolate, exporting to over 60 countries. Xinrui Group, with over 23 years in soy protein production and multiple certifications, targets Middle Eastern and Southeast Asian markets where Halal compliance is critical. Japan's Fuji Oil reported YEN 35.5 billion (USD 240 million) in soy-based ingredient sales in 2023, with 83% soybean traceability and RTRS membership since 2020, aligning with EU Deforestation Regulation requirements. India is scaling production with Epic Powder's energy-efficient air classification and micronization technology. Thailand, Indonesia, and South Korea import isolates from China and Japan for domestic manufacturing. Australia and New Zealand, though smaller markets, benefit from IFF's March 2026 heart-health claim approval, differentiating soy from pea and rice proteins.

Europe, South America, and the Middle East and Africa account for the remaining market share. Europe faces supply-chain restructuring due to EUDR compliance, which increases costs by 10 to 15%. Germany, France, and the UK lead consumption, driven by plant-based meat and dairy alternatives, while processors consolidate to manage traceability costs. In 2025, 54% of EU soy imports met FEFAC sustainability guidelines. Brazil and Argentina dominate South American production, exporting isolates to North America and Europe, while domestic consumption rises as local brands reformulate with soy proteins. ADM's 2021 acquisition of Sojaprotein in Serbia highlights the value of non-GMO production. The Middle East and Africa, as net importers, see demand led by the UAE, Saudi Arabia, and South Africa, with Halal and Kosher certifications favoring suppliers like Xinrui Group. Emerging markets such as Nigeria and Egypt are incorporating soy isolates into institutional foodservice and processed food manufacturing.

1. Archer Daniels Midland Company (ADM)
2. Bunge Global SA
3. International Flavors & Fragrances Inc.
4. Mitsubishi International Food Ingredients, Inc.
5. Ocean Health Co., Ltd.
6. Solbar Ningbo Protein Technology Co., Ltd.
7. Xinrui Group
8. Foodchem International Corp.
9. Shandong Sinoglory Protein Tech. Co.
10. Gushen Group
11. Shandong Yuwang Group
12. China Foodstuff & Protein Group Co., Ltd.
13. Farbest Brands
14. Universal Preservachem Inc.
15. Jiangsu Yiming Biological Technology Co., Ltd.
16. Andina Ingham
17. The Scoular Company
18. Laybio Natural
19. Shiv Health Foods LLP (PROWISE)
20. Fuji Oil Co., Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support